Of those, mutations with a detectable contribution to disease pathology, i.e., with the absence of HΒΒ expression (β0), significant reduction of HΒΒ expression (β+) or with an established contribution to at least thalassemia intermedia in compound heterozygote conditions, were analyzed further. Here, FUT1 is linked to beta-thalassemia intermedia.